Metabolic syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (12 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Metabolic syndrome}} | {{Metabolic syndrome}} | ||
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com] | {{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{RT}}; {{AN}} | ||
{{SK}} Metabolic syndrome X | {{SK}} Metabolic syndrome X; insulin resistance syndrome; Reaven syndrome; CHAOS (Australia); abdominal obesity-metabolic syndrome; dysmetabolic syndrome; plurimetabolic syndrome; hypertriglyceridemia waist syndrome; visceral fat syndrome; cardiometabolic syndrome; general cardiovascular syndrome | ||
==[[Metabolic syndrome overview|Overview]]== | ==[[Metabolic syndrome overview|Overview]]== | ||
==[[Metabolic syndrome historical perspective|Historical Perspective]]== | ==[[Metabolic syndrome historical perspective|Historical Perspective]]== | ||
==[[Metabolic syndrome classification|Classification]]== | |||
==[[Metabolic syndrome pathophysiology|Pathophysiology]]== | ==[[Metabolic syndrome pathophysiology|Pathophysiology]]== | ||
==[[Metabolic syndrome causes|Causes]]== | ==[[Metabolic syndrome causes|Causes]]== | ||
==[[Metabolic syndrome | ==[[Differentiating Metabolic syndrome from other diseases|Differentiating Metabolic Syndrome from other Diseases]]== | ||
==[[Metabolic syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Metabolic syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ||
| Line 19: | Line 22: | ||
==[[Metabolic syndrome risk factors|Risk Factors]]== | ==[[Metabolic syndrome risk factors|Risk Factors]]== | ||
==[[Metabolic syndrome natural history, complications and prognosis |Natural History, Complications and Prognosis]]== | |||
==[[Metabolic syndrome natural history, complications | |||
==Diagnosis== | ==Diagnosis== | ||
[[Metabolic syndrome history and symptoms|History and Symptoms]] | [[Metabolic syndrome physical examination|Physical Examination]] | [[Metabolic syndrome laboratory | [[Metabolic syndrome diagnostic criteria|Diagnostic Criteria]] | [[Metabolic syndrome history and symptoms|History and Symptoms]] | [[Metabolic syndrome physical examination|Physical Examination]] | [[Metabolic syndrome laboratory findings|Laboratory Findings]] | [[Metabolic syndrome electrocardiogram|Electrocardiogram]] | [[Metabolic syndrome chest x ray|Chest X Ray]] | [[Metabolic syndrome CT|CT]] | [[Metabolic syndrome MRI|MRI]] | [[Metabolic syndrome echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Metabolic syndrome other imaging findings|Other Imaging Findings]] |[[Metabolic syndrome other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Metabolic syndrome dietary therapy|Dietary Therapy]] | [[Metabolic syndrome physical activity|Physical Activity]] | [[Metabolic syndrome medical therapy|Medical Therapy]] | [[Metabolic syndrome surgery|Surgery]] | [[Metabolic syndrome primary prevention|Primary Prevention]] | [[Metabolic syndrome | [[Metabolic syndrome dietary therapy|Dietary Therapy]] | [[Metabolic syndrome physical activity|Physical Activity]] | [[Metabolic syndrome medical therapy|Medical Therapy]] | [[Metabolic syndrome surgery|Surgery]] | [[Metabolic syndrome primary prevention|Primary Prevention]] | [[Metabolic syndrome secondary prevention|Secondary Prevention]] | [[Metabolic syndrome tertiary prevention|Tertiary Prevention]] | [[Metabolic syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Metabolic syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
| Line 33: | Line 34: | ||
==Related Chapters== | ==Related Chapters== | ||
* [[Chronic Somogyi rebound]] | |||
* [[Hyperinsulinemia]] | * [[Hyperinsulinemia]] | ||
* [[Insulin resistance]] | * [[Insulin resistance]] | ||
| Line 43: | Line 44: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
Latest revision as of 18:45, 12 July 2016
For patient information click here
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2]; Raviteja Guddeti, M.B.B.S. [3]; Aarti Narayan, M.B.B.S [4]
Synonyms and keywords: Metabolic syndrome X; insulin resistance syndrome; Reaven syndrome; CHAOS (Australia); abdominal obesity-metabolic syndrome; dysmetabolic syndrome; plurimetabolic syndrome; hypertriglyceridemia waist syndrome; visceral fat syndrome; cardiometabolic syndrome; general cardiovascular syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Metabolic Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings |Other Diagnostic Studies
Treatment
Dietary Therapy | Physical Activity | Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Tertiary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies